Navigation Links
Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
Date:3/18/2013

LONDON, March 18, 2013 /PRNewswire/ -- Smith & Nephew (LSE: SN NYSE: SNN), the global medical technology business, is set to showcase its advanced portfolio of medical devices at this year's American Academy of Orthopaedic Surgeons (AAOS) meeting in Chicago, March 19-23.

New products highlighted at the show include the recently launched REDAPT™ Hip Revision System, the JOURNEY™ II BCS Knee, which incorporates VERILAST™ Technology in a knee replacement system that restores the anatomical shapes and more normal motion of the human knee, and a new Modular Rail System for deformity correction and limb restoration that was designed in collaboration with Dror Paley , MD.

Further illustrating the company's increased, strategic investment in fast-growing areas of the orthopaedic market is the ALL28™ foot and ankle portfolio, and a suite of industry-leading sports medicine technologies, including the FAST-FIX™ 360 Meniscal Repair System, the DYONICS™ Platinum Series Blades, and HEALICOIL™ PK, BIORAPTOR™ and OSTEORAPTOR™ Suture Anchors for joint repair.

Also highlighted will be the company's Advanced Wound Management (AWM) surgical incision management portfolio, led by the single-use, pocket-sized PICO™ Negative Pressure Wound Therapy system, one of a number of AWM products that  can help reduce orthopaedic surgical site complications, such as dehiscence or edema.

Additionally, a group of thought-leading orthopaedic surgeons, including Marc Philippon , MD, and Dror Paley , MD, will share their latest clinical results and innovative techniques as part of the Daily Workshop Series in Smith & Nephew's booth (booth #1218).

For the full schedule of speakers and featured technologies, visit Smith & Nephew's dedicated AAOS meeting website www.PowerSmithNephew.com. While at the show, follow the company on Twitter (@smithnephew) and Facebook (facebook.com/smithandnephew) for regular updates.

About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith & Nephew has almost 10,500 employees and a presence in more than 90 countries. Annual sales in 2012 were more than $4.1 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).

For more information about Smith & Nephew, please visit:  www.smith-nephew.com

Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in integrating acquired businesses, and disruption that may result from changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business or competitive nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors.

Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

Trademark of Smith & Nephew.  Registered US Patent and Trademark Office.


'/>"/>
SOURCE Smith & Nephew
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. TNI BioTech Acquires Exclusive License To The Portfilio Of Patents Of Dr Ian S. Zagon, Dr. Patricia J. McLauglin And Dr. Jill Smith From The Penn State Research Foundation
2. David Smith Named Vice President of Operations for HealthTell
3. Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
4. Law Office of Brodsky & Smith, LLC Announces Investigation of Complete Genomics, Inc.
5. Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters
6. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
7. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
8. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
9. The BioVoyage Institute Now Offering Hands-On Training Programs For Biotechnology Products & Applications
10. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
11. Updated Stock of Sapphire & Glass Ball Lenses Now Includes Fused Silica
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... TURIN, Italy , April 29, 2016 ... version 5.11, the latest update to its industry-leading treatment ... has shown that Monaco version ... Users can now attain calculation speeds up to four ... Monaco . With the industry,s gold standard ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... will deliver a talk on its first-in-class technologies for tissue stem cell counting ... on RNAiMicroRNA Biology to Reprogramming & CRISPR-based Genome Engineering in Burlington, Massachusetts. ...
(Date:4/27/2016)... ... 27, 2016 , ... Shimadzu Scientific Instruments (SSI) will be ... Business Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products ... can stop by booth 1021 to learn how Shimadzu’s instruments can help improve ...
(Date:4/27/2016)... SILVER SPRING, Md. and RESEARCH ... -- United Therapeutics Corporation (NASDAQ: UTHR ) announced ... Co-Chief Executive Officer, of United Therapeutics will provide an ... Deutsche Bank 41 st Annual Health Care Conference. ... May 5, 2016, at 10:00 a.m. Eastern Time, and ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):